Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03127228 · ClinicalTrials.gov registry record · NA
Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03127228: Completed NA study, sponsored by University of Michigan.
NCT03127228 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03127228, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate if using Erbium-doped yttrium aluminium garnet laser, Erbium YAG laser (Er:YAG) laser could have adjunctive benefits to the conventional standard mechanical debridement to ablate the infected tissue around the dental implant and detoxify the contaminated implant surface for resolving peri-implant infection and enhance bone regeneration of peri-implant defects.
Primary Outcome
PD will be measured in millimeters. Change in PD measurements were calculated between baseline and 24 weeks.
Interventions
- OTHER Standard mechanical debridement
- DEVICE Er:YAG laser-assisted debridement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2018-11-02 |
| Phase | NA |
What the finished NCT03127228 record still lists
NCT03127228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard mechanical debridement is the first listed.
NCT03127228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03127228 about?
NCT03127228 is a clinical study titled "Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis". The purpose of the study is to evaluate if using Erbium-doped yttrium aluminium garnet laser, Erbium YAG laser (Er:YAG) laser could have adjunctive benefits to the conventional standard mechanical debridement to ablate the infected tissue around the dental implant and detoxify the contaminated impla...
What is the current status of trial NCT03127228?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2017-06-26. Estimated completion is 2018-11-02.
What interventions are being tested in trial NCT03127228?
The interventions under investigation include: Standard mechanical debridement (OTHER), Er:YAG laser-assisted debridement (DEVICE).
Who is sponsoring clinical trial NCT03127228?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03127228's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI